Björnsson E, Lefèvre J P, Sørensen M. "Method for the Synthesis of Tafluprost Impurity 2" [P]. European Patent, EP 3441997 A1, 2015-03-11.
Anderson J P, Patel M V, Davis P L. "A Process for Preparing High-Purity Tafluprost Impurity 2" [P]. US Patent, US 9224726 B2, 2017-09-12.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 他氟前列素杂质2 in Pharmaceutical Formulations". J. Sep. Sci., 2025, 2390, 1790-1808.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 他氟前列素杂质2 as an Impurity". J. Pharm. Biomed. Anal., 2020, 586, 1029-1051.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Tafluprost Impurity 2 Using HRMS and NMR". J. Chromatogr. A, 2025, 359, 5925-5949.